NASDAQ: REGN $55 Billion Large-Cap. Nasdaq 100. S&P 500. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 10%. 1 Year Return 39%. 2020 YTD Return 36%. Since Earnings 22%.
For Starters
The 52 Week Low is $331.57 set on Thu, Jan 30, 2020.
The 52 Week High is $664.64 set on Mon, Jul 20, 2020.
The All-Time High is $664.64 set on Mon, Jul 20, 2020.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Regeneron Pharmaceuticals trades on the NASDAQ. REGN's market cap is 55.4 Billion.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products including: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.
Track your portfolio and more.
